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ABSTRACT
Objective: The present study aims to investigate the protective effect of methanol fraction of Morus alba (MEMA) leaves against hydrogen peroxide 
(H2O2)-induced U87MG cell toxicity and aluminum fluoride (ALF)-induced rat toxicity.
Methods: The study was divided into in vitro and in vivo sections. U87MG cell lines were pre-treated with different fractions of MEMA for 20 h 
and further tested against 1000 ϻM of H2O2. The best fraction from in vitro studies was used to study the protective effects against ALF-induced 
neurotoxicity. Rats were divided i nto five different groups, and MEMA (200 and 400 mg/kg p.o) was administered for 14 days to the animals with 
α-tocopherol as the standard drug treatment. Behavioral studies were assessed using Barnes maze. The major biochemical measurements included 
catalase, superoxide dismutase and glutathione reductase, lipid peroxidation (LPO), and acetylcholinesterase (AchE) levels.
Results: In vitro studies indicated MEMA as a potential candidate followed by AQMA and ethyl acetate. The MEMA fraction was able to ameliorate ALF-
induced neurotoxicity in the behavioral assessment. The higher antioxidant content in the fraction decreased the LPO levels from 250±4.07 to 115±3.22 
as well as elevated the levels of most of the endogenous antioxidant enzyme levels. AchE levels were also decreased to 33.89±0.71 from 38.94±0.64.
Conclusion: Although the results obtained indicate that MEMA could significantly suppress oxidative stress-induced central neuronal damage both 
in vitro and in vivo, further mechanistic studies are required to delineate its neuroprotective pathway.
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INTRODUCTION
Neurodegenerative diseases pose serious public health concerns with the 
most prevalent being Alzheimer’s disease (AD) followed by Parkinson’s 
disease (PD) [1]. About 5% of individuals aged 65 or older are affected by 
AD, whereas 1% of the individuals aged 60 years are affected by PD [2,3]. 
The evidence further suggests that AD will pose major neurological health 
concerns in the future [4]. AD accounts for 70% of cases of dementia, 
which displays progressive memory loss and cognitive dysfunction [5,6]. 
In 2010, the global cost of dementia was estimated at the United States 
(US) $604 billion and it crossed the US $1 trillion in 2018 [7].
Growing evidence points out oxidative stress and its associated 
consequences as one of the major risk factors for AD [8]. Oxidative 
stress describes a state of imbalance in the production of free radicals 
and antioxidant defenses [8,9]. Oxidative stress is implicated in the 
vicious circle of amyloid-beta production/accumulation, which is linked 
with AD development [10]. The primary reactive oxygen species (ROS) 
scavenging system is associated with oxidative stress, and in the brain, 
the system constitutes of the antioxidant enzymes such as catalase 
(CAT), superoxide dismutase (SOD), and glutathione reductase (GSH). 
Any imbalance to this system could pave ways to amassing of ROS in the 
system and disrupt the normal poise required to protect the neurons 
from oxidative injury. Thus, one promising preventive or therapeutic 
measure for neuroprotection could be to suppress or attenuate the ROS 
production/accumulation through the exogenous supply of antioxidants 
and regain the disrupted endogenous oxidative balance [6].
Hydrogen peroxide (H2O2) plays dual roles of ROS by itself and an 
initiator/precursor for other ROS. Increased utilization of oxygen 
in the tissues is associated with the higher production of H2O2 in the 
brain, which increases the risk of oxidative insult that can lead to 
apoptosis in various cell types [11]. Upon neurodegeneration, the 
brain undergoes extensive oxidative stress and rapid biogenic amine 
metabolism, all of which leads to exacerbation of H2O2 and other 
potential toxin accumulations [12]. Likewise, the neurotoxic role of 
aluminum fluoride (ALF) inducing the formation of the amyloid-beta 
has gained significance in many debates in the recent past within the 
western community. The complex is found to cause neurodegeneration 
mainly through excitotoxicity by activation of protein kinase C leading 
to erosion in the animal’s cognitive abilities.
Morus alba (MA) or the mulberry plant, whose biological name is MA 
Linn., is largely being cultivated in the areas of silk harvesting as a food 
for the silkworms. The medicinal values of the plant, mainly attributed its 
phenolic content [13], have come into light in a span of a few years. Our in-
house data suggest that the methanol fraction of MA (MEMA) leaves could 
be used as a protective agent owing to its hydroxyl radical scavenging 
and anticlastogenic activity [14]. Furthermore, our unpublished in-house 
data, the leaf extracts have shown protective effects in amyloid-beta 
and scopolamine-induced animal models by elevating the endogenous 
antioxidant enzyme levels providing a base to the present work [15]. The 
present work aims to identify the potent neuroprotective effect of MA leaf 
fraction by subjecting them to in vitro and in vivo antioxidant tests.
METHODS
Drugs and chemicals
Dulbecco’s Modified Eagle media (DMEM) and fetal bovine serum (FBS) 
were purchased from Gibco, Invitrogen. H2O2, ALF, sulforhodamine 
© 2019 The Authors. Published by Innovare Academic Sciences Pvt Ltd. This is an open access article under the CC BY license (http://creativecommons. 
org/licenses/by/4. 0/) DOI: http://dx.doi.org/10.22159/ajpcr.2019.v12i4.32359
Research Article
239
Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 238-243
 Raj et al. 
(SRB) dye, dichlorodihydrofluorescein diacetate (DCFH-DA), dimethyl 
sulfoxide (DMSO), acridine orange (AO), and ethidium bromide 
(EB) were procured from Sigma Aldrich. Thiobarbituric acid and 
trichloroacetic acid (TCA) were purchased from Hi-Media, Mumbai, 
India. All solvents (hexane [HEMA], petroleum ether [PEMA], ethyl 
acetate [ETMA], and methanol) used for extraction were of high-
performance liquid chromatography (HPLC) grade procured from 
Sigma Aldrich.
Plant collection and preparation of fractions
Fresh leaves were collected from Srirangapatna, Mysuru, India 
(12.4216° N, 76.6931° E), and the sample specimen was confirmed by 
Dr. Naganandini M.N, Department of Pharmacognosy, Jagadguru Sri 
Shivarathreeshwara College of Pharmacy, Mysuru, India. The leaves 
were sun dried for 2 days and powdered using a mechanical grinder. 
Exhaustive Soxhletion method was used for extraction. Coarse powder 
of the leaves was loaded in the thimble made of Whatman filter paper 
in the Soxhlet apparatus successively extracted with the solvents in the 
increasing order of polarity, namely n-HEMA, PEMA, ETMA, MEMA, and 
water (AQMA). 500 ml of each solvent was used for the extraction. Each 
of the fraction, i.e., HEMA, PEMA, ETMA, MEMA, and AQMA, respectively, 
were filtered, concentrated using flash rotary evaporator, dried, and 
stored in a vacuum desiccator at room temperature till use.
Cell lines
U87MG glioblastoma cell lines were procured from NCCS, Pune, and 
maintained in Jagadguru Sri Shivarathreeshwara Medical College. The 
cell lines were cultured in DMEM supplemented with 10% FBS and 1% 
penicillin at 37°C and 5% CO2.
Animals
All the experimental and animal handling procedures were approved by 
the Institutional Animal and Ethics Committee (IAEC) of Jagadguru Sri 
Shivarathreeshwara College of Pharmacy, Mysuru, India (IAEC approval 
number 153/2014). 30 Wistar rats of either sex weighing 250±50 g at 
the start of the experiment were used. The animals were housed in a 
temperature and light-controlled room (22°C, a 12 h dark and 12 h light 
cycle), fed, and allowed to drink AQMA ad libitum.
Drug administration
In in vitro studies, all the fractions were initially dissolved in DMSO 
and later diluted with the DMEM media. From pilot studies, we found 
that 10, 5, and 2.5 μg/ml of all the fractions were non-toxic to the cells. 
Hence, the non-toxic doses were used to perform the cell viability 
assays, and the best out of these test doses were selected for further 
assays. H2O2 in 1000 µM at 6h was found to exert maximum toxicity 
(50%) from prior cytotoxic dose (62.5-1000 µM) and time dependent 
(2,4 and 6h) studies.
In in vivo studies, ALF was administered at 600 ppm p.o to the animals 
from the 7th day of the 14 days experiment design. α-Tocopherol 
(100 mg/kg) and MEMA (200 and 400 mg/kg) were administered 
orally continuously for 14 days.
In vitro cell culture studies
Cell viability by SRB assay
The cytoprotective potential of MA extracts on U87MG glioblastoma 
cells was assessed using SRB assay [16]. A fixed number of cells 
(5000 cells/well) taken in a volume of 100 μL were added to each well 
of a flat-bottomed 96-well plate and kept in a CO2 incubator until 80% 
confluence of the cells for 48 h. The cells were treated with 100 μL 
all the fractions, namely HEMA, PEMA, ETMA, ALMA, and AQMA at 
concentrations of 10, 5, and 2.5 μg/ml for 20 h followed by 100 μL of 
1000 μM of H2O2 for 6 h. At the end of the 26th h, the cells were fixed 
with 50 μl of cold 10% (w/v) TCA for 1 h, washed with deionized AQMA 
to remove excess of TCA, dried, and stained with 100 μl of 0.4% (w/v) 
SRB dye solution for 30 min. The unbound SRB was then removed by 
washing with 1% acetic acid solution, and 100 μl of 10 mM aqueous tris 
base buffer was added to dissolve the dye. After thorough shaking, the 
optical density of the plate was read at 490 nm. The percentage viability 
was calculated by the formula shown in Equation 1:
PercentageViability
Avg Avg MB
Avg VC Avg MB

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100  Equation 1
Where,
Avg - Average of cells in each treatment wells
Avg (MB) - Average of the media blank (only media)
Avg (VC) - Average of cells in vehicle control.
ROS measurement by DCFH-DA
Fixed number of U87MG cells (5000 cells/well) was seeded in 96-
well plate. Upon 80% confluence, cells were treated with 2.5 μg/ml of 
MEMA. Briefly, the cells were pre-treated with 2.5 μg/ml of methanol 
extract for 20 h. The media was removed and washed once with PBS 
and incubated with DCFH-DA solution (20 μM/well) for 30 min. The 
cells were then treated with 1000 μM of H2O2 for 6 h. Finally, at the 
end of the 6th h, the fluorescence intensity (FI) of DCF was measured 
in a microplate reader with an excitation wavelength of 485 nm and an 
emission wavelength of 535 nm [17].
Fluorescent imaging by dual staining
Dual staining with EB and AO was performed [18]. Fixed number of 
U87MG cells (5000 cells) were treated with MEMA (2.5 μg/ml) and 
1000 μM of H2O2. Upon completion of the treatment, the cells were 
trypsinized and suspended in PBS (25 μL) from each group and were 
mixed with 1 μL AO/EB for 15 min just before microscopic evaluation. 
A thin smear of stained cells was prepared on microscopic slides. 
Images were captured using a fluorescent microscope.
In vivo neuroprotective study
Experimental
The rats were divided into five groups of six each: (1) Control group 
received saline treatment (0.9% NaCl), (2) standard group received 
α-tocopherol pre-treatment followed by ALF (600 ppm) treatment for 
7 days, (3) ALF (600 ppm) alone-treated group, (4) MEMA leaves pre-
treated group received ALF treatment for 7 days (MEMA1 [200 mg/kg] 
+ ALF), and (5) MEMA leaves (MEMA2 [400 mg/kg] + ALF) pre-treated 
group received ALF treatment for 7 days. Control and ALF alone-treated 
groups were caged in the same conditions but in the absence of the 
treatment.
Spatial learning and memory-Barnes maze task
Spatial learning and memory of the experimental animals were tested 
by the Barnes maze [15,19]. The apparatus consisted of a clear circular 
platform (13 cm×29 cm×14 cm) with 12 equally spaced holes (10 cm 
diameter) located 2 cm from the border. The circular platform was virtually 
divided into four zones (including the target quadrant with the escape 
hole and the opposite quadrant). Each trial began by placing the animal in 
a black cylinder at the center of the platform that was removed after 10 s, 
allowing mice to freely explore the apparatus. The spatial acquisition was 
organized in four training sessions (day 1 and 2–2 trails/day). Rats that 
failed to find the target box within 3 min were gently guided to its location, 
and for those rats, 180 s were recorded as the escape latency. All animals 
remained in the target box for 60 s after entering.
The following parameters were scored during all training trials: Latency 
to escape and a total number of errors. Escape latency was defined as 
the time taken by animals to completely enter the target box (all four 
paws out of the platform). Total errors were defined as the total number 
of holes visited during the trial other than the target hole. A hole was 
considered visited when rats tilted their head over it (nose poke) or 
introduced their paws into the hole.
On day 14, reference short-term memory was evaluated by a probe trial 
(90 s) during which the target box was removed. The latency to find 
240
Asian J Pharm Clin Res, Vol 12, Issue 4, 2019, 238-243
 Raj et al. 
the target hole (without box) was determined. Furthermore, rats were 
once again submitted to the acquisition trial in the same conditions 
to evaluate long-term retention. No training occurred between days 
7 and 14.
Estimation of the endogenous antioxidant enzymes and lipid 
peroxidation (LPO)
The rats were decapitated under anesthesia (ketamine) [20]. The 
skull was cut open, and the brain was exposed from its dorsal side. 
The whole brain was quickly removed and cleaned with chilled 0.1 M 
sodium phosphate buffer (pH 7.4). A 10% (w/v) homogenate of brain 
samples (0.1 M sodium phosphate buffer, pH 7.4) were prepared using 
homogenizer and then centrifuged at 4000 rpm for 10 min at 4°C. The 
supernatant homogenate was used to measure, total protein content 
(Spinreact), and the activities of CAT, SOD, GSH, and LPO based on the 
standard methods [21-24].
Determination of acetylcholinesterase (AchE) activity
The AchE enzymatic assay was determined by spectrophotometric 
method [25]. The reaction mixture (2 ml final volume) contained 
100 mM potassium phosphate buffer, pH 7.5 and 1 mM 
5,5′-dithiobisnitrobenzoic acid. The method is based on the formation 
of the yellow anion, 5,5′-dithio-bis-acidnitrobenzoic, measured by 
absorbance at 412 nm during 2-min incubation at 25°C. The reaction 
was initiated by adding 0.8 mM acetylthiocholine iodide. All samples 
were run in triplicate, and change in absorbance per minute is recorded 
in the kinetic mode of a spectrophotometer for 3 min at 412 nm.
Statistical analysis
Data are shown as means ± standard error of the mean (SEM). Statistical 
analysis was performed using Prism 5 (GraphPad). One-way and two-
way repeated measures ANOVA followed by Tukey’s and Bonferroni 
post hoc analysis were used for probe day and training trials data, 
respectively. The level of significance was set at p<0.05.
RESULTS
Cytoprotective activity of MA fractions against H2O2-induced 
cytotoxicity
U87MG cells were pre-treated with 10, 5, and 2.5 µg/ml of all the 
fractions for 20 h, and cytotoxicity was induced using H2O2 for 6 h. All 
fractions except PEMA reduced the cytotoxicity induced by H2O2, but 
pre-treatment with MEMA at 2.5 µg/ml significantly increased the 
cell viability compared to H2O2-treated cells and as well as the control 
(Table 1).
ROS generation by dichlorodihydrofluorescein diacetate
Cells were pre-treated with MEMA for 20 h and further treated with 
H2O2 for 6 h. The conversion of non-fluorescent DCFH-DA to fluorescent 
DCF in the presence of ROS was fluorometrically detected. MEMA 
(2.5 μg/ml) being the most effective dose was used to determine the 
ROS scavenging activity for providing evidence to the prior in vitro 
antioxidant results as well as a base to the dose selection for in vivo 
studies. MEMA (2.5 μg/ml) could scavenge the H2O2 generated ROS 
compared to the H2O2-treated group but could not bring back to the 
normal levels (Table 2).
Fluorescent imagining by dual staining
Fluorescent staining of U87MG cells was performed using AO/EB for 
qualitative analysis. MEMA pre-treated cells showed significant cell 
viability (green color) compared to the H2O2 treatment, whereas H2O2-
treated cells showed significant cell death compared to control. The 
images were captured using fluorescent microscope (Olympus) (Fig. 1).
Effect of MEMA on spatial learning and memory by Barnes maze
The ALF-treated group significantly increased mean escape 
latencies throughout the training days when compared with normal. 
α-tocopherol significantly reduced the escape latencies and number 
of error compared to ALF-treated group and significantly increased 
the time spent in escape quadrant. MEMA also at both the doses 
significantly succeeded in shortening the escape latencies prolonged 
by ALF treatment as well as number of errors made. In the probe 
trial, MEMA1 (Table 3) (200 mg/kg) pre-treated group significantly 
increased the time spent in the escape quadrant as compared to the 
standard treatment (Fig. 2).
Table 1: Effect of Morus alba leaf fractions on H2O2-induced cell 
death in U87MG cell lines (n = 3)
Group Treatment % viability
1 Control 87.89 ± 0.97
2 H2O2 49 ± 2.13a
3 HEMA (10 µg/ml) 63.21 ± 3.24b
4 HEMA (5 µg/ml) 59.21 ± 5.81a,b
5 HEMA (2.5 µg/ml) 50.30 ± 6.94a
6 PEMA (10 µg/ml) 57.13 ± 4.7a, b
7 PEMA (5 µg/ml) 50.12 ± 3.99a 
8 PEMA (2.5 µg/ml) 48.98 ± 4.5a
9 ETMA (10 µg/ml) 77.01 ± 7.12b
10 ETMA (5 µg/ml) 71.31 ± 6.87b
11 ETMA (2.5 µg/ml) 80.42 ± 4.94b
12 MEMA (10 µg/ml) 88.17 ± 5.92b
13 MEMA (5 µg/ml) 91.53 ± 3.36b
14 MEMA (2.5 µg/ml) 97.04 ± 5.55b
15 AQMA (10 µg/ml) 79.17 ± 3.73b
16 AQMA (5 µg/ml) 83.87 ± 6.82b
17 AQMA (2.5 µg/ml) 86.96 ± 5.91b
Data were analyzed by one-way ANOVA followed by post hoc Tukey’s multiple 
comparison test. ap < 0.05 compared to control blank and bp < 0.05 compared 
to H2O2. H2O2: Hydrogen peroxide, HEMA: Hexane, PEMA: Petroleum ether, 
ETMA: Ethyl acetate, MEMA: Methanol fraction of Morus alba
Table 2: Effect of MEMA on H2O2-induced ROS generation in 





MEMA (2.5 µg/ml) 111.38b
MEMA (2.5 µg/ml)+ H2O2 129.25a,b
Data were analyzed by one-way ANOVA followed by post hoc Tukey’s multiple 
comparison test. ap<0.05 compared to control blank and bp<0.05 compared to 
H2O2. H2O2: Hydrogen peroxide, ROS: Reactive oxygen species, MEMA: Methanol 
fraction of Morus alba
Fig. 1: Dual-stained images of treated and control cells under 
fluorescent microscope. Figures represent the different treated 
cells and the cell blank after dual staining viewed under 
fluorescent microscope. (a) Cell blank, (b) vehicle control 
(dimethyl sulfoxide), (c) methanol fraction of Morus alba (MEMA) 
(2.5 µg/ml), (d) hydrogen peroxide (H2O2) (1000 µM for 6 h), and 
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Effect of MEMA on endogenous antioxidant enzymes
Reports indicate that the endogenous antioxidant enzyme levels are 
found least in the brain compared to other organs [26]. Hence, it is 
important to check the levels of these enzymes pre- and post-treatment 
to confirm the antioxidant efficacy of the fraction. After ALF treatment, 
rat brains showed a marked decrease in SOD, GSH, and CAT levels when 
compared with normal. α-tocopherol (100 mg/kg i.p) significantly 
increased the decline in ALF-induced brain endogenous enzymes 
while the treatment with MEMA at both doses (200 and 400 mg/kg) 
significantly reversed the dropped brain enzymes level (Table 4).
Effect of MEMA on brain AchE activity
Acetylcholine is considered to be very important in proper brain 
functions especially memory and related cognitive domains. AchE 
enzyme causes breakdown of Ach leading to its loss of activity. The 
direct levels of Ach measurement are a bit tedious due to the highly 
sensitive and unstable nature of the neurotransmitter, and hence, the 
levels of AchE are estimated to indirectly give a measurement of Ach 
levels in the brain [27]. AchE activity in normal animals was found to 
be 27.72±1.77 μM/min/mg protein. AchE activity was significantly 
increased in animals treated with ALF (38.94±0.64) when compared 
with normal. MEMA at 200 and 400 mg/kg and standard significantly 
reversed the increase in AchE activity treated by ALF (Table 5).
Effect of MEMA on LPO
The LPO levels are one of the most important markers of oxidative 
stress. Lipids when reacting with free radicals undergo peroxidation 
to form lipid peroxides indirectly indicating the free radical 
density [28]. The MEMA1 treatment not only significantly reduced the 
malondialdehyde (MDA) formed due to ALF-induced stress compared 
to the control group but also the values were analogous the standard 
treatment (Table 6).
DISCUSSION
Ample evidence from preclinical and clinical studies prove the role of 
oxidative stress in the pathogenesis of neurodegenerative diseases. 
The oxygen-free radicals are found to play an important role in the 
decline of the health status of the elderly [29]. Finding novel and 
effective treatment agents that modify the disease course through 
neuroprotective therapy either by slowing down disease progression or 
promoting the genesis of new neurons are an unmet clinical need [30]. 
Exogenous administration of antioxidants to scavenge the generated 
free radicals and strengthen the endogenous antioxidant enzymes is one 
such treatment strategy. Plants and its products are splendid sources 
of antioxidants and hence have been used for its therapeutic benefits 
and to increase the effectiveness of treatment. The MEMA leaves are 
found to exert beneficial effects comparable to Ginkgo biloba for AD in 
addition to its anti-Aβ aggregation effect in primary hippocampal cell 
cultures at a concentration of 30 mg/ml [31]. With this aim, the present 
study was selected to explore the possible neuroprotective activity of 
leaves of MA against H2O2 cytotoxicity and ALF-induced neurotoxicity.
As mentioned earlier, H2O2 is a generator as well as a propagator 
of ROS in the living system. An elevation in H2O2 levels correlates 
with the toxic consequences of AD and Aβ, and reports suggest that 
Aβ increases H2O2 accumulation in the cells indicating a “second 
messenger” role of H2O2 which induces apoptosis [32]. In-vitro studies 
have also demonstrated  morphological and biochemical similarities 
between amyloid beta and H2O2 induced neurotoxicities [33]. Hence, 
we presumed in our study that levels of cytoprotection extended 
by the fractions against H2O2-induced toxicity could also provide 
an indirect mechanism for their neuroprotective activity against 
Aβ-induced toxicity.
Fractions were subjected to in vitro neuroprotective assay on the 
human glioblastoma cell lines (U87MG) against H2O2-induced 
cytotoxicity. The U87MG cells pre-treated with all the fractions followed 
by H2O2 (1000lo) treatment 6 h were found to resist death in most of 
the groups except for PEMA but actually increased the number of cells 
in the MEMA group possibly due to its higher antioxidants, especially 
phenolic content [14]. Due to the significant protective effect of the 
methanol fraction at 2.5 µg/ml, it was selected for further studies. As 
discussed earlier, hydroxyl radicals are identified to be one of the major 
contributors to aging and most of the chronic diseases. In addition, 
direct exposure of H2O2 has been reported to block glutathione 
biosynthesis and induce oxidative stress, resulting in apoptotic cell 
death [34]. Our previous in-house data indicated a prominent hydroxyl 
radical scavenging activity for the MEMA fraction. Hence, there was a 
requirement of reproducibility for the same effect in a living system for 
which FI produced on conversion of DCFH-DA to DCF in the presence 
of ROS (which also includes OH radicals) was estimated. MEMA 2.5 µg/
ml readily scavenged H2O2 generated ROS and markedly decreased the 
FI compared to the H2O2. Further, fluorescent imaging was performed 
to qualitatively confirm the protective mechanism of MEMA at 2.5 µg/
ml. The results supported the protective data obtained from the above 
assays. The significant antioxidant ability of MEMA might delay the 
occurrence of apoptosis or prevent it altogether.
From numerous neurotoxins, ALF particularly stands out due to the 
combination of two potent neurotoxins: ALF. Being individually toxic, 
Table 3: Effect of MEMA on probe trial in Barnes maze (n=6)







Data were analyzed by one-way ANOVA followed by post hoc Tukey’s multiple 
comparison test where ap<0.05 compared to normal, bp<0.05 compared to 
ALF, cp<0.05 compared to standard. MEMA: Methanol fraction of Morus alba, 
ALF: Aluminum fluoride
Fig. 2: Effect of methanol fraction of Morus alba (MEMA) on spatial learning and memory by Barnes maze. (a) Effect of MEMA on 
escape latencies in Barnes maze and (b) effect of MEMA on total number of errors made in Barnes maze. All values were expressed as 
mean ± standard error of the mean, n=6. Data were analyzed by two-way ANOVA followed by post hoc Bonferroni’s multiple comparison test. 
ba
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their combination is found to be highly neuronal degrading since 
the complex interferes with most of all the neurochemical functions 
including impairing glutamate transporters and microglial activation 
all of which finally leading to excitotoxicity. The toxin is found to 
significantly increase the ROS/reactive nitrogen species and LPO 
products leading to mitochondrial dysfunction ultimately facilitating 
the accumulation of neurodegenerative products such as Aβ and tau. 
Al, being an abundant metal, and fluoride, a component of drinking 
water, possess many chances in our everyday lives to react and form the 
deadly “AlF duo” [12,35]. Hence, the model is important to be studied to 
predict its consequences likely to be posed to human society.
Previous investigations and in vitro studies carried out indicate 
methanol fraction to be more active compared to other fractions. Hence, 
the MEMA fractions at doses of 200 and 400 mg/kg were chosen for 
in vivo studies directed against ALF-induced neurotoxicity. The escape 
latency and number of errors were assessed using Barnes maze. 
MEMA at 200 and 400 mg/kg dose substantially shortened the escape 
latencies prolonged by ALF and also reduced the total number of errors 
made by the animals while acquisition. MEMA1 (200 mg/kg) had an 
effect comparable to the standard. The cognitive enhancement could be 
due to PDE4 inhibition by Moracin present in the leaves leading to the 
increased cyclic adenosine monophosphate levels in the hippocampus 
indicated in memory enhancement [36].
The evaluation of biochemical parameters was performed to support 
the data obtained from the behavioral studies. In comparison with 
control, the fraction at both the doses considerably decreased the AchE 
activity, but MEMA1 showed similar efficacy as that of the α-tocopherol 
group in the reduction MDA levels. The decreased AchE activity may 
be attributed to the antiserotonergic effect of MEMA fraction which 
assists in the enhanced release of Ach from the cortical area [37]. Both 
the doses of MEMA considerably increased the levels of CAT, SOD, and 
GSH, when compared to AlF treated group with MEMA1 exhibiting a 
slightly increased activity, correlating to our previous antioxidant 
activity reports.
CONCLUSION
The present study indicated that pre-exposure to MEMA leaves could 
effectively restore antioxidant brain status both in vitro and in vivo and 
may confer neuroprotection due to the alleviation of oxidative damage 
induced by two different toxins. Therefore, MEMA could be a potential 
candidate for the further preclinical study aimed at the moderation of 
dementia symptoms in neurodegenerative diseases.
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